Jan 8, 2021 16:23
3 yrs ago
20 viewers *
English term
Ukraine
Marketing, Legal & Finance
Native in: Ukrainian (Variant: Standard-Ukraine) 
, Russian (Variant: Standard-Russia)
Works in: English to Russian, English to Ukrainian, Russian to English, and 5 more.
Heart Failure development for Finerenone
English to Russian
Medical
Medical: Health Care
As MD with Board Certification in Cardiology and Internal Medicine, she joined XXX in 2010 as Global Medical Expert within Clinical Development.
During her career, Mrs. A has held several key positions, including serving as Global Clinical Leader leading the Heart Failure development for Finerenone, laying the foundation for the recently announced Phase III trial in Heart Failure.
In her previous role as XXX’s Head of Studies & Pipeline within the Cardiovascular therapeutic area of Medical Affairs, Mrs. A was responsible for the life cycle program of rivaroxaban.
During her career, Mrs. A has held several key positions, including serving as Global Clinical Leader leading the Heart Failure development for Finerenone, laying the foundation for the recently announced Phase III trial in Heart Failure.
In her previous role as XXX’s Head of Studies & Pipeline within the Cardiovascular therapeutic area of Medical Affairs, Mrs. A was responsible for the life cycle program of rivaroxaban.
Proposed translations
(Russian)
| 4 +2 | исследования финеренона при лечении сердечной недостаточности |
Mark Rabkin
|
| 3 | исследование сердечной недостаточности при применении финеренона |
Andrey Kirsanov
|
Proposed translations
+2
29 mins
Selected
исследования финеренона при лечении сердечной недостаточности
4 KudoZ points awarded for this answer.
Comment: "Selected automatically based on peer agreement."
5 hrs
Andrey Kirsanov
Ukraine
Ukraine
Native in Russian
Specializes in field
Ukraine
M.D. in oncology and pathology
Native in: Russian (Variant: Standard-Russia)
Works in: English to Russian, Russian, Ukrainian to Russian, and 2 more.
исследование сердечной недостаточности при применении финеренона
Далее в тексте говорится, что она заложила основы третьей фазы испытаний при изучении сердечной недостаточности. Можно предположить, что Миссис А возглавляла исследования именно сердечной недостаточности при разработке финеренона.
Something went wrong...